This invention relates to methods of treating various orofacial diseases
involving inflammation, infection and/or pain, using intratissue
controlled release drug delivery systems. More particularly, the
invention relates to methods for localized or targeted administration of
a sustained release formulation of an agent such as an anti-inflammatory
agent to a specified tissue location within the orofacial environment.